The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) and the University of Delaware, on behalf of NIIMBL, have entered into a collaborative research and development agreement (CRADA) with the FDA.    Effective July 15, 2019, the FDA and NIIMBL will have the ability to collaborate in a pre-competitive environment to strengthen research, innovation, training, and collaboration in the biopharmaceutical manufacturing industry. This CRADA will enable FDA and NIIMBL to su...